Company intelligence / Profile preview

HiDO Health

San Francisco, California, United Stateshidohealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

HiDO’s robotic caregiver platform has demonstrated significant clinical results, including an 80% reduction in hospitalizations among congestive heart failure patients and documented self-driven care among dementia patients. In dementia trials, the device achieved 100% success measuring immediate and delayed recall. The technology is fully operational, FDA Class I exempt, used in NIH/NIA research projects, and has been deployed for over five years.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: DeviceAI robotics platformDigital biomarker monitoring system
Industry: Digital Health Medical Devices

Partnerships

National Institute on Aging / NIH SBIR programAcademic medical centersMedicare Advantage payersLong-term care insurance providersMail-order pharmacies

Beyond the preview

Go deeper on HiDO Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HiDO Health.

Explore the full profile